CURX: Curanex Pharma Company Short-Term Debt

Symbol and logo of brand Curanex Pharma (CURX)

Curanex Pharmaceuticals Inc specializes in the therapy of gastrointestinal pathologies while facing regulatory challenges and patent pressure. Short-term debt statistics visualize these risks, with the 0.00 metric indicating the status of the credit load. The business focuses on optimizing drug formulas to increase efficiency. Environmental policy remains restrained, limited to energy saving and digital document management in offices.

CURX (curanexpharma.com) Company Short-Term Debts history from 08/27/2025 to 10/31/2026

Analytical breakdowns for Curanex Pharmaceuticals Inc

- current quotes and average value forecast:
Price Chart Curanex|CURX - Fair Value Consensus
- market capitalization information:
Market Value Curanex Pharmaceuticals Inc|CURX - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Curanex Pharmaceuticals|CURX - Book Capitalization|Market Cap to Net Assets Ratio curanexpharma.com|CURX - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Curanex Pharmaceuticals Inc|CURX - Long-Term Indebtedness to Equity|Short-Term Debt to Capital Curanex|CURX - Company Total Debt Obligations|Debt to Book Value Curanex Pharmaceuticals Inc|CURX - Amount of Long-Term Liabilities|Company Short-Term Debts Curanex Pharmaceuticals|Quick Liquidity Indicator curanexpharma.com
- net income and valuation multiples indicators:
CURX - Net Profit
Fundamental company analysis:curanexpharma.com - CURX
Manufactured products of Curanex Pharma

The total volume of liabilities maturing within one year determines the business's vulnerability to liquidity shocks, measuring the company's ability to service urgent payments without external support. For Curanex Pharmaceuticals Inc (CURX), whose R&D expenses are rising in the absence of marketable products, the change in short-term liabilities on this chart serves as an indicator of critical dependence on external financing amid locked margins.

Who Curanex Pharmaceuticals Inc competes with

PHAT - Company Short-Term Debt|Company Short-Term Loans and Borrowings TERN (Terns Pharma)|ironwoodpharma.com (IRWD) - Company Short-Term Debt|Company Current Liabilities Immuron|EVOK (Evoke Pharma, Inc.) - Company Short-Term Debts|Company Short-Term Debts Entero|Company Current Liabilities RDHL (RedHill Biopharma)|PALI (palisadebio.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts JAGX (Jaguar Animal Health)|Short-Term Indebtedness Biora Therapeutics, Inc|Morphic Holding, Inc. - Company Short-Term Debts